Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
Focus
 
Making Peptides for Presentation
Contents Editorial Reviews Research Highlights
NPG Library Classics Feedback
 Classics
 Proteasomes

The author describe the first real PA28ab double-knockout mouse and present experimental evidence that PA28 is essential for the generation of a specific epitope in vivo.

Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β
Murata, S., Udono, H,, Tanahashi, N., Hamada, N,, Watanabe, K,, Adachi, K,, Yamano, T., Yui, K., Kobayashi, N., Kasahara, M., Tanaka, K. & Chiba, T.
Pubmed

The authors show that PA28 can induce structural and functional changes on the 20S proteasome.

Lysine 188 substitutions convert the pattern of proteasome activation by REGγ to that of REGs α and β
Li, J., Gao, X., Ortega, J., Nazif, T., Joss, L., Bogyo, M., Steven, A.C. & Rechsteiner, M.
Pubmed

The authors demonstrate that the proteasome repertoire influences T cell selection.

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products
Toes, R.E., Nussbaum, A.K., Degermann, S., Schirle, M., Emmerich, N.P., Kraft, M., Laplace, C., Zwinderman, A., Dick, T.P., Muller, J., Schonfisch, B., Schmid, C., Fehling, H.J., Stevanovic, S., Rammensee, H.G. & Schild, H.
Pubmed

The paper describes experiments showing that immunoproteasomes enhance the production of N-terminally elongated peptides.

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide
Cascio, P., Hiltton, C., Kisselev, A.F., Rock, L. & Goldberg, A.L.
Pubmed

An excellent study showing that infection induces immunoproteasome formation in the target tissue.

Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver
Kahn, S., van den Broek, M., Schwarz, K., Guili, R., Diener, P. & Groettrup, M.
Pubmed

These two reports provide compelling evidence against the dogma that antigenic peptides were products of protein-turn over. Most peptides were in fact derived from newly synthesized proteins.

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Anton, L.C., Gibbs, J., Norbury, C.C., Yewdell, J.W. & Bennink, J.R.
Abstract | Full text | PDF
The major substrates for TAP in vivo are derived from newly synthesized proteins.
Reits, E.A., Vos, J.C., Gromme, M. & Neefjes, J.
Abstract | Full text | PDF

The first report that describes an IFN-γ independent inducible system for immunoproteasome formation and shows that only low amounts of immunoproteaomes are needed for an effective immune response.

MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells
Sijts, A, Standera, S., Beekmann, N., van Veelen, P.A., Ossendorp, F.A., Melief, C.J. & Kloetzel, P.M.
Pubmed

The authors provide evidence that POMP is upregulated by IFN-γ treatment.

Characterization of the newly identified human Ump1 homologue POMP and analysis of LMP7 (β5i) incorporation into 20S proteasomes
Witt, E., Zantopf, D., Schmidt, M., Kraft, R., Kloetzel, P.M. & Krüger, E.
Pubmed

The paper provides a structural explanation for the experimentally observed gating function of PA28.

Structural basis for the activation of 20S proteasomes by 11S regulators
Whitby, F.G., Master, E.I., Kramer, L., Knowlton, J.R., Yao, Y., Wang, C.C. & Hill, C.P.
Abstract | Full text | PDF

The authors provide a detailed biochemical study of the functional and structural properties of PI31.

cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome
McCutchen-Maloney, S.L,. Matsuda, K., Shimbara, N., Binns, D.D., Tanaka, K., Slaughter, C.A. & DeMartino, G.N.
Pubmed

This study presents evidence that proteasomes may not function in a completely processive way. The authors also discuss the possibility that 20S proteasomes take up substrates that are cut down to size by aminopeptidases.

Lysozyme degradation by the bovine multicatalytic proteinase complex (proteasome): evidence for a nonprocessive mode of degradation
Wang, R., Chait, B.T., Wolf, I., Kohanski, R.A. & Cardozo, C.
Pubmed

This study show that there are at least two distinct proteolytic steps involved in the generation of a MHC class I—presented peptide in living cells. Proteasomes are needed to make initial cleavages in an antigen and are the only protease in living cells that could generate the proper C terminus of a presented peptide. A second proteolytic step trims extra residues from the N terminus of precursors to generate the mature presented peptide.

Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide
Craiu, A., Akopian, T., Goldberg, A. & Rock, K.L.
Pubmed
Incorporation of major histocompatibility complex encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ
Kuckelkorn, U., Frentzel, S., Kraft, R., Kostka, S., Groettrup, M. & Kloetzel, P.M.
Pubmed

The first report implicating the proteasome as a generator of antigenic peptides. This study identified proteasome inhibitors and demonstrated that they block the degradation of most cell proteins and also the production of most MHC class I presented peptides. In contrast, these agents did not block the presentation of mature peptides injected or expressed in the cytosol of cells. These findings demonstrate that the majority of MHC class I—presented peptides are generated by the proteasomes.

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D. & Goldberg, A.L.
Pubmed

The authors show for the first time that 20S proteasomes have the potential to generate epitopes in vitro and that immunoproteasomes exhibit an altered cleavage site preference.

IFN-γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes
Boes, B., Hengel, H., Ruppert, T., Multhaup, G., Koszinowski, U. & Kloetzel, P.M.
Pubmed

These two papers reported that the MHC-encoded proteasomal subunits altered the peptidase activity of the proteasome. These findings provided the first evidence that these subunits helped to form the active sites of the proteolytic complex and altered how cleavages would be made in substrates.

γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes
Gaczynska, M., Rock, K.L. & Goldberg, A.L.
Abstract | PDF
MHC-linked LMP gene products specifically alter peptidase activities of the proteasome
Driscoll, J., Brown, M.G., Finley, D. & Monaco, J.J.
Abstract | PDF

This study showed that proteasomes incorporate two additional subunits encoded in the MHC class II region in the presence of interferon-γ (IFN-γ). This complex was eventually renamed the immunoproteasomes. This observation provided circumstantial evidence for a connection between proteasomes and the immune system. The involvement of the 'MHC-encoded' subunits and of the immune function of the proteasome was unknown.

Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes
Brown, M.G., Driscoll, J. & Monaco, J.J.
Abstract | PDF

First paper studying the mechanism of antigen generation and peptide loading of MHC class I molecules. The authors showed that the proteasome is somehow involved in this process.

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen
Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S. & Smith, G.
Pubmed

One of the first reports that describes the rapid degradation of newly synthesized proteins.

Significance of rapid degradation of newly synthesized proteins in mammalian cells: A working hypothesis
Wheatley, D., Grisola, S. & Hernandez-Yago, J.
Pubmed
 
ADVERTISEMENT
Register-TOCRegister for table of contents e-alerts
RecommendRecommend to your library
ReceiveReceive news feeds
what is a news feed?
 
ADVERTISEMENT
 
Nature Immunology
ISSN: 1529-2908
EISSN: 1529-2916
Journal home | Advance online publication | Current issue | Archive | Press releases | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works ©1998 - 2006 Nature Publishing Group | Privacy policy